- Trials with a EudraCT protocol (86)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
86 result(s) found for: Clinical social work.
Displaying page 1 of 5.
EudraCT Number: 2018-002650-67 | Sponsor Protocol Number: IBERepic/2018 | Start Date*: 2018-11-15 |
Sponsor Name:Ibermutuamur (Mutua Colaboradora con la Seguridad Social nº 274) | ||
Full Title: Comparison of the efficacy of autologous platelet rich plasma injections, and extracorporeal shock wave therapy, in the treatment of work –related lateral epicondylitis. | ||
Medical condition: The epicondylitis is an overuse injury, in most cases, is a self-limited course and responds well to conservative treatment. Its etiology is degenerative and is related to a repetitive overuse and ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004094-17 | Sponsor Protocol Number: 40-41200-98-9269 | Start Date*: 2015-11-03 | |||||||||||
Sponsor Name:Universiteit Utrecht | |||||||||||||
Full Title: Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias. | |||||||||||||
Medical condition: Phobic anxiety disorders: either generalized social phobia or panic disorder with agoraphobia. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000942-21 | Sponsor Protocol Number: AIMS-2-CT1 | Start Date*: 2019-07-24 | |||||||||||||||||||||
Sponsor Name:Celso Arango | |||||||||||||||||||||||
Full Title: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents w... | |||||||||||||||||||||||
Medical condition: Autism Spectrum Disorder | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003052-70 | Sponsor Protocol Number: APAC2016 | Start Date*: 2016-11-10 | |||||||||||
Sponsor Name:Academic Medical Center of Amsterdam | |||||||||||||
Full Title: Initial non-operative treatment strategy versus appendectomy treatment strategy for simple appendicitis in children aged 7-17 years old. APAC study | |||||||||||||
Medical condition: Acute uncomplicated (simple) appendicitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002592-34 | Sponsor Protocol Number: RID-TB:Dx | Start Date*: 2020-08-28 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: Research to Improve the Detection and Treatment of Latent Tuberculosis Infection: Diagnostics (RID-TB:Dx) A randomised controlled trial to evaluate the effectiveness of using the RD-1 based C Tb s... | |||||||||||||
Medical condition: Latent Tuberculosis infection (LTBI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004548-31 | Sponsor Protocol Number: HUB-PSI-CAMAD | Start Date*: 2020-04-18 | ||||||||||||||||
Sponsor Name:Cinto Segalàs | ||||||||||||||||||
Full Title: A RANDOMIZED, CONTROLLED, OPEN AND UNICENTRIC PHASE II CLINICAL TRIAL, WITH TWO PARALLEL GROUPS, TO EVALUATE THE ANTIDEPRESSANT EFFICACY OF PSYCHOTHERAPY AND CITALOPRAM IN WOMEN DIAGNOSED WITH BREA... | ||||||||||||||||||
Medical condition: Female patients diagnosed with breast cancer who, during the first year following the diagnosis of oncological disease, have affective symptomatology that meets DSM-V criteria for major depression. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-002108-11 | Sponsor Protocol Number: SEP380-303 | Start Date*: 2022-02-10 | |||||||||||
Sponsor Name:Sunovion Pharmaceuticals Inc. | |||||||||||||
Full Title: A 12-Month Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Effectiveness of SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated ... | |||||||||||||
Medical condition: Major Depressive Episodes Associated with Bipolar I Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Prematurely Ended) SK (Prematurely Ended) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004803-39 | Sponsor Protocol Number: SA-NXY-0007 | Start Date*: 2005-10-07 |
Sponsor Name:AstraZeneca AB | ||
Full Title: SAINT II (Stroke - Acute Ischemic - NXY Treatment) A double blind, randomized, placebo controlled, parallel group, multicenter, phase IIb/III study to assess the efficacy and safety of intravenous ... | ||
Medical condition: Acute ischemic stroke. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) HU (Completed) SK (Completed) ES (Completed) BE (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001552-37 | Sponsor Protocol Number: RG07-066(FormerlyHTA02/06/02) | Start Date*: 2008-07-25 |
Sponsor Name:University of Birmingham | ||
Full Title: Effectiveness and Cost-effectiveness of Levonorgestrel containing Intrauterine system in Primary care against Standard Treatment for menorrhagia | ||
Medical condition: Menorrhagia | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002219-69 | Sponsor Protocol Number: CHUBX2019/49 | Start Date*: 2021-07-19 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Long-term iron chelation in the prevention of secondary degeneration after cerebral infarction | ||
Medical condition: Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002773-21 | Sponsor Protocol Number: 89Zr-TLX250-003 | Start Date*: 2019-04-10 |
Sponsor Name:TELIX International Pty Ltd | ||
Full Title: A confirmatory, prospective, open-label, multi-centre phase 3 study to evaluate diagnostic performance of 89Zirconium-labelled girentuximab(89Zr-TLX250) to non-invasively detect clear cell renal ce... | ||
Medical condition: Patients with an indeterminate renal mass (IRM) detected on contrast-enhanced abdominal MR imaging or equivalent standard of care imaging, clinically suspicious for renal cell carcinoma and schedul... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) GB (GB - no longer in EU/EEA) BE (Completed) ES (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2014-004077-16 | Sponsor Protocol Number: 14/0249 | Start Date*: 2014-12-03 | |||||||||||
Sponsor Name:University College London Joint Research Office | |||||||||||||
Full Title: A Phase IV randomised controlled trial of the selective serotonin reuptake inhibitor Sertraline versus Cognitive Behavioural Therapy for anxiety symptoms in people with Generalised Anxiety Disorder... | |||||||||||||
Medical condition: Generalised anxiety disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001422-25 | Sponsor Protocol Number: ITA-BGT-12-10389 | Start Date*: 2013-06-11 | |||||||||||
Sponsor Name:Biogen Idec Italia S.r.l. | |||||||||||||
Full Title: Single country study assessing cognition in Relapsing Remitting Multiple Sclerosis patients treated with BG00012 | |||||||||||||
Medical condition: Relapsing Remitting Multiple Sclerosis (RRMS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000346-18 | Sponsor Protocol Number: BST-SCI-02 | Start Date*: 2021-06-28 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: A phase I/II, randomized, double-blind, placebo-controlled, parallel, 2-arms clinical trial to assess the safety and efficacy of intrathecal administration of WJ-MSC in chronic traumatic cervical i... | |||||||||||||
Medical condition: Cronic traumatic spinal cord injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005975-13 | Sponsor Protocol Number: V00114 CP 201 | Start Date*: 2006-04-25 |
Sponsor Name:PIERRE FABRE MEDICAMENT | ||
Full Title: Randomised, double-blind, placebo-controlled dose-effect study of V0114 (2.5, 5, 7.5 and 10 mg) versus mequitazine 10 mg and placebo in the treatment of seasonal allergic rhinitis. | ||
Medical condition: Prospective, multicentric, international, randomised, double-blind trial in six parallel groups: 4 doses of the test product, active control and placebo. This study is intended to evaluate the ef... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: CZ (Completed) FR (Completed) EE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003243-21 | Sponsor Protocol Number: TRANSGRIPE 1-2 | Start Date*: 2011-10-17 | |||||||||||
Sponsor Name:Fundación Pública Andaluza Progreso y Salud | |||||||||||||
Full Title: Randomized, comparative and prospective clinical trial evaluating efficacy and safety of a dose of seasonal flu vaccine compared to two doses of vaccine for prevention of influenza in solid organ t... | |||||||||||||
Medical condition: seasonal influenza prophylaxis in trasplant receipiens | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003867-13 | Sponsor Protocol Number: CL2-47445-014 | Start Date*: 2016-02-15 | |||||||||||
Sponsor Name:Institut de Recherches internationales Servier | |||||||||||||
Full Title: Efficacy and safety of S 47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy. A randomised, double-blind, pla... | |||||||||||||
Medical condition: Major depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FI (Completed) SK (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002802-21 | Sponsor Protocol Number: PRIMERA001 | Start Date*: 2020-12-18 | ||||||||||||||||
Sponsor Name:Erasmus Medical Center | ||||||||||||||||||
Full Title: PeRsonalIzed MEdicine in Rheumatoid Arthritis (PRIMERA trial): a multicenter, single-blinded, randomized controlled trial comparing usual care with a tailor-made approach | ||||||||||||||||||
Medical condition: Rheumatoid arthritis according to 2010 criteria | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018963-40 | Sponsor Protocol Number: CRO1498 | Start Date*: 2011-04-14 |
Sponsor Name:Imperial College London | ||
Full Title: A multi-centre, double-blind, individually randomised, placebo-controlled, parallel arm RCT with 12-week follow-up to establish the clinical and cost effectiveness of amisulpride augmentation of cl... | ||
Medical condition: Schizophrenia that has proved unresponsive to standard treatment and a subsequent trial of clozapine | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-000219-18 | Sponsor Protocol Number: PsiloRCT001 | Start Date*: 2018-04-09 | ||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||
Full Title: Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms | ||||||||||||||||||
Medical condition: Major Depressive Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
